Krystal Biotech Inc
NASDAQ:KRYS
Krystal Biotech Inc
NASDAQ:KRYS
Price:
272.745
USD
2.19%
Market Closed
Market Cap:
$7.9B
Income Statement
Earnings Waterfall
Krystal Biotech Inc
Krystal Biotech Inc
Income Statement
Krystal Biotech Inc
Krystal Biotech Inc
Currency: USD
| Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
9
N/A
|
51
+492%
|
96
+89%
|
166
+73%
|
242
+45%
|
291
+20%
|
333
+15%
|
359
+8%
|
373
+4%
|
389
+4%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(3)
|
(6)
|
(12)
|
(18)
|
(20)
|
(23)
|
(24)
|
(21)
|
(23)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
8
N/A
|
48
+471%
|
90
+90%
|
155
+71%
|
224
+44%
|
270
+21%
|
311
+15%
|
335
+8%
|
352
+5%
|
366
+4%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(1)
|
(2)
|
(2)
|
(4)
|
(5)
|
(7)
|
(8)
|
(9)
|
(12)
|
(14)
|
(18)
|
(20)
|
(22)
|
(23)
|
(24)
|
(29)
|
(33)
|
(41)
|
(51)
|
(57)
|
(68)
|
(79)
|
(92)
|
(107)
|
(120)
|
(131)
|
(141)
|
(143)
|
(145)
|
(146)
|
(151)
|
(159)
|
(167)
|
(177)
|
(184)
|
(194)
|
(205)
|
|
| Selling, General & Administrative |
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(5)
|
(6)
|
(6)
|
(6)
|
(7)
|
(9)
|
(12)
|
(15)
|
(21)
|
(27)
|
(32)
|
(40)
|
(48)
|
(56)
|
(67)
|
(78)
|
(86)
|
(94)
|
(98)
|
(98)
|
(100)
|
(102)
|
(107)
|
(114)
|
(120)
|
(128)
|
(137)
|
(147)
|
|
| Research & Development |
(1)
|
(1)
|
(1)
|
(3)
|
(3)
|
(4)
|
(6)
|
(6)
|
(8)
|
(9)
|
(12)
|
(14)
|
(16)
|
(16)
|
(15)
|
(17)
|
(18)
|
(21)
|
(24)
|
(25)
|
(28)
|
(31)
|
(35)
|
(41)
|
(42)
|
(45)
|
(47)
|
(46)
|
(46)
|
(45)
|
(49)
|
(51)
|
(54)
|
(57)
|
(56)
|
(57)
|
(58)
|
|
| Operating Income |
(1)
N/A
|
(2)
-41%
|
(2)
-32%
|
(4)
-83%
|
(5)
-22%
|
(7)
-38%
|
(8)
-26%
|
(9)
-11%
|
(12)
-30%
|
(14)
-20%
|
(18)
-24%
|
(20)
-13%
|
(22)
-10%
|
(23)
-6%
|
(24)
-5%
|
(29)
-18%
|
(33)
-15%
|
(41)
-25%
|
(51)
-23%
|
(57)
-12%
|
(68)
-20%
|
(79)
-16%
|
(92)
-16%
|
(107)
-17%
|
(120)
-12%
|
(131)
-9%
|
(141)
-7%
|
(135)
+4%
|
(97)
+28%
|
(55)
+43%
|
4
N/A
|
65
+1 512%
|
103
+59%
|
134
+29%
|
152
+14%
|
158
+4%
|
161
+2%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(3)
|
(3)
|
(3)
|
(3)
|
1
|
1
|
1
|
2
|
3
|
3
|
3
|
3
|
2
|
1
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
1
|
3
|
5
|
9
|
13
|
18
|
23
|
27
|
29
|
30
|
30
|
29
|
29
|
29
|
28
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(25)
|
(25)
|
(25)
|
(25)
|
(13)
|
(13)
|
88
|
88
|
88
|
75
|
(38)
|
(38)
|
(25)
|
(13)
|
0
|
0
|
|
| Pre-Tax Income |
(1)
N/A
|
(2)
-43%
|
(2)
-34%
|
(7)
-225%
|
(8)
-11%
|
(10)
-21%
|
(11)
-16%
|
(9)
+23%
|
(11)
-27%
|
(13)
-18%
|
(16)
-24%
|
(17)
-9%
|
(19)
-9%
|
(20)
-6%
|
(22)
-7%
|
(27)
-24%
|
(32)
-19%
|
(43)
-33%
|
(52)
-22%
|
(58)
-11%
|
(70)
-20%
|
(104)
-49%
|
(115)
-11%
|
(130)
-12%
|
(140)
-8%
|
(135)
+3%
|
(140)
-4%
|
(30)
+79%
|
13
N/A
|
59
+358%
|
108
+83%
|
57
-47%
|
95
+66%
|
138
+45%
|
169
+22%
|
187
+11%
|
189
+1%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
(2)
|
(5)
|
(6)
|
(14)
|
(22)
|
12
|
15
|
|
| Income from Continuing Operations |
(1)
|
(2)
|
(2)
|
(7)
|
(8)
|
(10)
|
(11)
|
(9)
|
(11)
|
(13)
|
(16)
|
(17)
|
(19)
|
(20)
|
(22)
|
(27)
|
(32)
|
(43)
|
(52)
|
(58)
|
(70)
|
(104)
|
(115)
|
(130)
|
(140)
|
(135)
|
(140)
|
(30)
|
11
|
57
|
106
|
52
|
89
|
124
|
147
|
199
|
205
|
|
| Net Income (Common) |
(1)
N/A
|
(2)
-43%
|
(2)
-34%
|
(7)
-225%
|
(8)
-11%
|
(10)
-21%
|
(11)
-16%
|
(9)
+23%
|
(11)
-27%
|
(13)
-18%
|
(16)
-24%
|
(17)
-9%
|
(19)
-9%
|
(20)
-6%
|
(22)
-7%
|
(27)
-24%
|
(32)
-19%
|
(43)
-33%
|
(52)
-22%
|
(58)
-11%
|
(70)
-20%
|
(104)
-49%
|
(115)
-11%
|
(130)
-12%
|
(140)
-8%
|
(135)
+3%
|
(140)
-4%
|
(30)
+79%
|
11
N/A
|
57
+423%
|
106
+85%
|
52
-51%
|
89
+70%
|
124
+39%
|
147
+18%
|
199
+36%
|
205
+3%
|
|
| EPS (Diluted) |
-0.13
N/A
|
-0.19
-46%
|
-0.26
-37%
|
-0.69
-165%
|
-0.77
-12%
|
-0.92
-19%
|
-1.08
-17%
|
-0.82
+24%
|
-0.97
-18%
|
-0.89
+8%
|
-1.09
-22%
|
-1
+8%
|
-1.2
-20%
|
-1.17
+3%
|
-1.18
-1%
|
-1.37
-16%
|
-1.71
-25%
|
-2
-17%
|
-2.34
-17%
|
-2.61
-12%
|
-3.13
-20%
|
-4.13
-32%
|
-4.51
-9%
|
-5.06
-12%
|
-5.49
-8%
|
-5.28
+4%
|
-5.26
+0%
|
-1.03
+80%
|
0.39
N/A
|
1.95
+400%
|
3.57
+83%
|
1.77
-50%
|
3
+69%
|
4.15
+38%
|
4.91
+18%
|
6.66
+36%
|
6.84
+3%
|
|
Switch to:
Switch to:
See Also
Discover More
